NCT02914509: A trial that was reported late by Ocular Therapeutix, Inc.
This trial has reported, although it was 395 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02914509 |
|---|---|
| Title | A Prospective, Multicenter, Randomized, Parallel-Arm, Double Masked, Vehicle Controlled Phase 3A Study Evaluating the Safety and Efficacy of OTX-TP in the Treatment of Subjects With Open-Angle Glaucoma or Ocular Hypertension |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 7, 2016 |
| Completion date | March 30, 2019 |
| Required reporting date | March 29, 2020, midnight |
| Actual reporting date | April 29, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 395 |